Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net income including noncontrolling interests	$ 290,446	$ 255,810
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization	79,556	71,261
Impairment and other charges	0	16,055
Share-based compensation expenses related to equity classified awards	23,862	39,163
Non-cash restructuring and other related charges	0	4,329
Amortization of program rights	610,099	601,640
Amortization of deferred carriage fees	24,747	16,138
Unrealized foreign currency transaction gain	(1,098)	(10,025)
Amortization of deferred financing costs and discounts on indebtedness	5,778	5,820
Loss on extinguishment of debt	0	22,074
Bad debt expense	2,035	4,900
Deferred income taxes	46,292	31,765
Gain on investments	(4,084)	(4,554)
Other, net	(7,854)	(3,429)
Changes in assets and liabilities:
Accounts receivable, trade (including amounts due from related parties, net)	99,711	38,514
Prepaid expenses and other assets	(18,174)	(62,799)
Program rights and obligations, net	(1,065,937)	(967,172)
Income taxes payable	13,181	(5,235)
Deferred revenue	66,822	6,837
Deferred carriage fees, net	(22,285)	(29,207)
Accounts payable, accrued liabilities and other liabilities	(106,506)	12,099
Net cash provided by operating activities	36,591	43,984
Cash flows from investing activities:
Capital expenditures	(33,510)	(29,969)
Return of capital from investees	1,771	0
Payments for acquisition of a business, net of cash acquired	0	(19,072)
Acquisition of investments	(5,002)	(28,397)
Cash paid on distribution of business	0	(7,052)
Loans to investees	(2,456)	0
Principal payment received on loan to investee	720	20,000
Proceeds from sale of investments	9,854	95,370
Net cash provided by (used in) investing activities	(28,623)	30,880
Cash flows from financing activities:
Proceeds from the issuance of long-term debt	0	986,000
Principal payments on long-term debt	(25,313)	(1,015,000)
Deemed repurchases of restricted stock units	(21,557)	(32,343)
Proceeds from stock option exercises	0	9,795
Principal payments on finance lease obligations	(2,606)	(2,866)
Contributions from noncontrolling interests	0	2,701
Distributions to noncontrolling interests	(28,232)	(14,906)
Purchase of noncontrolling interests	(2,500)	0
Net cash used in financing activities	(80,208)	(66,619)
Net increase (decrease) in cash and cash equivalents from operations	(72,240)	8,245
Effect of exchange rate changes on cash and cash equivalents	(29,051)	(25,804)
Cash and cash equivalents at beginning of period	892,221	888,526
Cash and cash equivalents at end of period	$ 790,930	$ 870,967